Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06759610Completed
Randomised, single-blind trial of tetracycline in unicystic ameloblastoma (UA) (2 arms), sponsored by Minia University. Primary endpoint: Radiographic assessment CBCT at 6 months. Started Feb 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06759610.